{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:48:59Z","timestamp":1790686139244,"version":"4.1.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[1997,11,1]],"date-time":"1997-11-01T00:00:00Z","timestamp":878342400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chest"],"published-print":{"date-parts":[[1997,11]]},"DOI":"10.1378\/chest.112.5.1175","type":"journal-article","created":{"date-parts":[[2008,1,22]],"date-time":"2008-01-22T22:31:17Z","timestamp":1201041077000},"page":"1175-1179","source":"Crossref","is-referenced-by-count":47,"title":["FK 506 \u2018Rescue\u2019 Immunosuppression for Obliterative Bronchiolitis After Lung Transplantation"],"prefix":"10.1016","volume":"112","author":[{"given":"David J.","family":"Ross","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael Ian","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Vo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Kass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1378\/chest.112.5.1175_bib1","first-page":"638","article-title":"Cytomegalovirus infection and survival in lung transplant recipients","volume":"10","author":"Duncan","year":"1991","journal-title":"J Heart Lung Transplant"},{"key":"10.1378\/chest.112.5.1175_bib2","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1164\/ajrccm\/147.4.1017","article-title":"Cytomegalovirus infection and pneumonitis: impact after isolated lung transplantation","volume":"147","author":"Ettinger","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.112.5.1175_bib3","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1378\/chest.107.4.973","article-title":"Bronchiolitis obliterans in recipients of single, double, and heart-lung transplantation","volume":"107","author":"Keller","year":"1995","journal-title":"Chest"},{"key":"10.1378\/chest.112.5.1175_bib4","first-page":"713","article-title":"A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts","volume":"12","year":"1993","journal-title":"J Heart Lung Transplant"},{"key":"10.1378\/chest.112.5.1175_bib5","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/00000658-199309000-00010","article-title":"A decade of lung transplantation","volume":"218","author":"Griffith","year":"1993","journal-title":"Ann Surg"},{"key":"10.1378\/chest.112.5.1175_bib6","first-page":"3260","article-title":"Reduced incidence of acute, refractory acute, and chronic rejection after liver transplantation with FK 506-based immunosuppression","volume":"26","year":"1994","journal-title":"Transplant Proc"},{"key":"10.1378\/chest.112.5.1175_bib7","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1097\/00007890-199205000-00017","article-title":"Conversion of liver allograft recipients from cyclosporine to FK 506 immunosuppressive therapy\u2014a clinicopathologic study of 96 patients","volume":"53","author":"Demetris","year":"1991","journal-title":"Transplantation"},{"key":"10.1378\/chest.112.5.1175_bib8","first-page":"T299","article-title":"Standardization of spirometry\u2014 1987 update","volume":"136","year":"1987","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.112.5.1175_bib9","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1378\/chest.86.6.824","article-title":"Post-transplant obliterative bronchiolitis and other late lung sequelae in human heart-lung transplantation","volume":"86","author":"Burke","year":"1984","journal-title":"Chest"},{"key":"10.1378\/chest.112.5.1175_bib10","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1097\/00007890-198905000-00030","article-title":"Efficacy of transbronchial biopsy in the diagnosis of bronchiolitis obliterans in heart-lung transplant recipients","volume":"47","author":"Yousem","year":"1989","journal-title":"Transplantation"},{"key":"10.1378\/chest.112.5.1175_bib11","first-page":"3240","article-title":"FK 506 rescue therapy for irreversible airway rejection in heart-lung transplant recipients: report on five cases","volume":"26","author":"Knoop","year":"1994","journal-title":"Transplant Proc"},{"key":"10.1378\/chest.112.5.1175_bib12","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/0003-4975(95)00407-C","article-title":"Clinical trial of tacrolimus versus cyclosporine in lung transplantation","volume":"60","author":"Keenan","year":"1995","journal-title":"Ann Thorac Surg"},{"key":"10.1378\/chest.112.5.1175_bib13","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1378\/chest.107.4.967","article-title":"Bronchiolitis obliterans in single-lung transplant recipients","volume":"107","author":"Nathan","year":"1995","journal-title":"Chest"},{"key":"10.1378\/chest.112.5.1175_bib14","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/00007890-199602150-00019","article-title":"Cytolytic therapy for the treatment of bronchiolitis obliterans syndrome following lung transplantation","volume":"61","author":"Kesten","year":"1996","journal-title":"Transplantation"},{"key":"10.1378\/chest.112.5.1175_bib15","series-title":"FK 506 is superior to OKT3 for rescue therapy in cases of persistent rejection after intrathoracic transplantation","first-page":"A254","author":"Meiser","year":"1996"},{"key":"10.1378\/chest.112.5.1175_bib16","doi-asserted-by":"crossref","unstructured":"Millis JM, Cronin DC, Newell KA, et al. Tacrolimus treatment of steroid resistant rejection provides economic advantages compared to OKT3 therapy. Dallas: American Society of Transplant Physicians 15th Annual Meeting, 1996; A128","DOI":"10.1016\/S0041-1345(96)00671-9"},{"key":"10.1378\/chest.112.5.1175_bib17","unstructured":"1995 Drug Pharmaceutical Red Book"},{"key":"10.1378\/chest.112.5.1175_bib18","unstructured":"Nair RV, Huang X, Morris RE, et al. Rapamycin but not leflunomide directly inhibits proliferation of human adult lung fibroblasts in response to growth factor stimuli. Dallas: American Society of Transplant Physicians 15th Annual Meeting, 1996; A142"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215472964?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215472964?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T01:18:57Z","timestamp":1684199937000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369215472964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,11]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1997,11]]}},"alternative-id":["S0012369215472964"],"URL":"https:\/\/doi.org\/10.1378\/chest.112.5.1175","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[1997,11]]}}}